105 related articles for article (PubMed ID: 9258351)
1. Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells.
Fenick DJ; Taatjes DJ; Koch TH
J Med Chem; 1997 Aug; 40(16):2452-61. PubMed ID: 9258351
[TBL] [Abstract][Full Text] [Related]
2. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
Taatjes DJ; Fenick DJ; Koch TH
J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
[TBL] [Abstract][Full Text] [Related]
3. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
Taatjes DJ; Fenick DJ; Koch TH
Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
[TBL] [Abstract][Full Text] [Related]
4. Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
Taatjes DJ; Gaudiano G; Resing K; Koch TH
J Med Chem; 1997 Apr; 40(8):1276-86. PubMed ID: 9111302
[TBL] [Abstract][Full Text] [Related]
5. Production of formaldehyde and DNA-adriamycin or DNA-daunomycin adducts, initiated through redox chemistry of dithiothreitol/iron, xanthine oxidase/NADH/iron, or glutathione/iron.
Taatjes DJ; Gaudiano G; Koch TH
Chem Res Toxicol; 1997 Sep; 10(9):953-61. PubMed ID: 9305576
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition, nuclear uptake, and retention of anthracycline-formaldehyde conjugates in prostate cancer cells relative to clinical anthracyclines.
Taatjes DJ; Koch TH
Anticancer Res; 1999; 19(2A):1201-8. PubMed ID: 10368676
[TBL] [Abstract][Full Text] [Related]
7. Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
Taatjes DJ; Gaudiano G; Resing K; Koch TH
J Med Chem; 1996 Oct; 39(21):4135-8. PubMed ID: 8863788
[No Abstract] [Full Text] [Related]
8. Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA.
Post GC; Barthel BL; Burkhart DJ; Hagadorn JR; Koch TH
J Med Chem; 2005 Dec; 48(24):7648-57. PubMed ID: 16302805
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
Burke PJ; Koch TH
J Med Chem; 2004 Feb; 47(5):1193-206. PubMed ID: 14971899
[TBL] [Abstract][Full Text] [Related]
10. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
Povarov LS; Leont'eva OV; Bernaki PD; Olsuf'eva EN; Salimova EI; Pera P; Preobrazhenskaia MN
Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-formaldehyde conjugate, doxoform: induction of apoptosis relative to doxorubicin.
Burke PJ; Koch TH
Anticancer Res; 2001; 21(4A):2753-60. PubMed ID: 11724351
[TBL] [Abstract][Full Text] [Related]
12. Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde.
Barthel BL; Mooz EL; Wiener LE; Koch GG; Koch TH
J Med Chem; 2016 Mar; 59(5):2205-21. PubMed ID: 26881291
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of epidoxorubicin-formaldehyde virtual crosslink of DNA and evidence for its formation in human breast-cancer cells.
Podell ER; Harrington DJ; Taatjes DJ; Koch TH
Acta Crystallogr D Biol Crystallogr; 1999 Sep; 55(Pt 9):1516-23. PubMed ID: 10489446
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics.
Studzian K; Wasowska M; Piestrzeniewicz MK; Wilmańska D; Szmigiero L; Oszczapowicz I; Gniazdowski M
Neoplasma; 2001; 48(5):412-8. PubMed ID: 11845988
[TBL] [Abstract][Full Text] [Related]
15. Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells.
Taatjes DJ; Koch TH
Curr Med Chem; 2001 Jan; 8(1):15-29. PubMed ID: 11172689
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric measurement of formaldehyde generated in breast cancer cells upon treatment with anthracycline antitumor drugs.
Kato S; Burke PJ; Fenick DJ; Taatjes DJ; Bierbaum VM; Koch TH
Chem Res Toxicol; 2000 Jun; 13(6):509-16. PubMed ID: 10858324
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.
Ghirmai S; Mume E; Tolmachev V; Sjöberg S
Carbohydr Res; 2005 Jan; 340(1):15-24. PubMed ID: 15620662
[TBL] [Abstract][Full Text] [Related]
18. Sequence specificity of formaldehyde-mediated covalent binding of anthracycline derivatives to DNA.
Szulawska A; Gniazdowski M; Czyz M
Biochem Pharmacol; 2005 Jan; 69(1):7-18. PubMed ID: 15588709
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
20. Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera.
Cogan PS; Koch TH
J Med Chem; 2004 Nov; 47(23):5690-9. PubMed ID: 15509168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
